| 前收市價 | 1.3500 |
| 開市 | 1.3500 |
| 買盤 | 0.9500 |
| 賣出價 | 1.4500 |
| 拍板 | 195.00 |
| 到期日 | 2024-11-15 |
| 今日波幅 | 1.3500 - 1.3500 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 5 |
ZacksLabcorp Stock Gains From Its Latest Acquisition of BioReference Health
LH completes the acquisition of BioReference Health, a wholly-owned subsidiary of OPKO Health. The acquisition includes BioReference Health's laboratory testing businesses.
ZacksLabcorp Stock Gains From Market Expansion Efforts Amid Macro Woes
LH is well-placed for long-term success in Cell & Gene Therapy, expanding into the consumer market and international growth through the specialty testing and biopharma business.
ZacksLH Stock Expected to Gain From the Ballad Health Acquisition Deal
Labcorp has reached an agreement to purchase select outreach laboratory services from Ballad Health.
